A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

NCT00964730 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Talampanel
DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]